Risk score of drug-induced liver injury among new tuberculosis patients

D. Ivanova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation)

Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Session: Challenges in treating tuberculosis and nontuberculous mycobacteria
Session type: Poster Discussion
Number: 523
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Ivanova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation). Risk score of drug-induced liver injury among new tuberculosis patients. 523

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Frequency, severity and risk factors of drug-induced liver injury during treatment of new tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012

Management of tuberculosis in patients with chronic liver dysfunction
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007

Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007

Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019

Risk factors for tuberculosis in patients with chronic alcoholism
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021

Risk factors predicting mortality in patients with lung abscess
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Effectiveness of treatment and correction of side effects in pulmonary MDR/XDR TB patients with concomitant liver injury
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017

Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007

Clinical assessment for identifying causes of acute respiratory failure in cancer patients
Source: Eur Respir J 2013; 42: 435-443
Year: 2013

Pulmonary disease as a risk factor for transfusion-related acute lung injury
Source: ERJ Open Res, 7 (3) 00039-2021; 10.1183/23120541.00039-2021
Year: 2021

Risk factors for fatal tuberculosis among immunocompetent patients.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Treatment approach to tuberculosis in patients with antituberculotic-induced liver disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 650s
Year: 2005

Study of lung functions in patients of chronic liver disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017

Risk factors of hepatotoxicity during tuberculosis treatment and management
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008

A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Risk factors for pulmonary Mycobacterium avium-intracellulare complex disease deterioration in immunocompetent patients
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Risk factors associated with death in pulmonary tuberculosis
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009

Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020

Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients
Source: Eur Respir J 2011; 38: 643-648
Year: 2011